Used as main image by Phynd in search results and profile page

Shelly S. Lo, MD

Hematology & Oncology

Services & Specialties

Areas of Specialization

  • Hematology & Oncology

Clinical Interests

Conditions Treated

  • cancer chemotherapy
  • breast cancer chemotherapy
  • breast cancer biological targeted therapy
  • adjuvant chemotherapy
  • neoadjuvant chemotherapy
  • breast cancer genetic testing
  • breast cancer therapy

About

My practice is focused on the treatment of breast cancer, counseling patients at risk of developing breast cancer, and supporting patients through their cancer journey.

Academic Title

Professor

Additional Resources

Education & Certifications

Education

Education:
Mount Holyoke College (1992)

Education:
State University of New York at Brooklyn (1997)

Residency:
Albany Medical Center (2001)

Fellowship:
Mount Sinai School of Medicine (2002)

Fellowship:
University of Pittsburgh Medical Center (2004)

Board Certifications

Medical Oncology, Medical Oncology, American Board of Internal Medicine Subspecialty (2004)

Provider Ratings

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn More >

4.8 out of 5

(88 ratings)

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

26 Reviews

06/24/2024

She is the best!

06/19/2024

Very nice

06/17/2024

Dr. Lo is wonderful

05/06/2024

I felt that Dr. Lo really listen to me and my health concerns

04/29/2024

I am proud to be a patient at Loyola.

04/24/2024

Dr. Lo is great. I thought I would really miss Dr. Robinson, but Dr. Lo treats me with great respect and understands my needs.

04/24/2024

�

04/23/2024

Loyola personnel & Dr were amazing

03/27/2024

I received high quality care. Dr.Lo very caring and compassionate.

03/20/2024

Very good wouldn’t want anyone else

03/06/2024

Keep on with the good work.

12/27/2023

Always polite and friendly, and professional.

12/20/2023

Good �

11/16/2023

Too long waiting for doctor

11/15/2023

So glad she’s back

11/11/2023

Good meeting, look forward to going forward.

11/08/2023

Positive experience

10/25/2023

Everything is excellent

10/21/2023

Room clean, comfortable temperature

10/06/2023

This is specific to Dr. Lo.

08/30/2023

Dr, Lo is one of the best oncologist Loyola has who really cares about her patients.

08/25/2023

Im going to truly miss seeing her, since i don't have to go back, but she said if i have any problems call or make an appointment.

08/21/2023

I have complete trust in Dr. Lo as my physician.

08/16/2023

My experience with the nurse practitioner was excellent

08/12/2023

Very good communication

07/07/2023

Dr. Shelly Lo is an excellent oncologist. I would highly recommend/refer Dr. Shelly Lo to friends or others. I want to mention that Dr. Patricia Robinson, is another excellent oncologist at Loyola. .
Show more

Publications

  • Anti-aquaporin-4 immunoglobulin G/anti-myelin oligodendrocyte glycoprotein immunoglobulin G double-positive paraneoplastic neurological syndrome in a patient with triple-negative breast cancer. Siddiqui, A.; Ross, D.; Jani, R. H.; Prabhu, V. C.; Lo, S.; Wainwright, D. A.; Rouse, S.; Refaat, T.; Zhu, Y.; Thakkar, J. P.; Clinical & experimental neuroimmunology
  • Concurrent Hospice Healthcare Utilization in the Hematology/Oncology Veteran's Affairs Patient Population. Hemrajani, A.; Lo, S.; Vahlkamp, A.; Silva, A.; Limaye, S.; The American journal of hospice & palliative care
  • Evaluation of the Novel 4R Oncology Care Planning Model in Breast Cancer: Impact on Patient Self-Management and Care Delivery in Safety-Net and Non-Safety-Net Centers. Trosman, J. R.; Weldon, C. B.; Rapkin, B. D.; Benson, A. B.; Makower, D. F.; Liang, S. Y.; Kulkarni, S. A.; Perez, C. B.; Lo, S. S.; Krueger, E. A.; Throckmorton, A. D.; Gallagher, C.; Hoskins, K.; Schaeffer, C. M.; Van Horn, J.; Schapira, L.; Ravelo, A.; Yu, E.; Gradishar, W. J.; JCO oncology practice
  • Role of Imaging in Renal Cell Carcinoma: A Multidisciplinary Perspective. Abou Elkassem, A. M.; Lo, S. S.; Gunn, A. J.; Shuch, B. M.; Dewitt-Foy, M. E.; Abouassaly, R.; Vaidya, S. S.; Clark, J. I.; Louie, A. V.; Siva, S.; Grosu, A. L.; Smith, A. D.; Radiographics : a review publication of the Radiological Society of North America, Inc
  • Outcomes of Specialty Palliative Care Interventions for Patients With Hematologic Malignancies: A Systematic Review. Elliott, E.; Watson, T.; Singh, D.; Wong, C.; Lo, S. S.; Journal of pain and symptom management
  • Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial. I-SPY2 Trial Consortium; Yee, D.; DeMichele, A. M.; Yau, C.; Isaacs, C.; Symmans, W. F.; Albain, K. S.; Chen, Y. Y.; Krings, G.; Wei, S.; Harada, S.; Datnow, B.; Fadare, O.; Klein, M.; Pambuccian, S.; Chen, B.; Adamson, K.; Sams, S.; Mhawech-Fauceglia, P.; Magliocco, A.; Feldman, M.; Rendi, M.; Sattar, H.; Zeck, J.; Ocal, I. T.; Tawfik, O.; LeBeau, L. G.; Sahoo, S.; Vinh, T.; Chien, A. J.; Forero-Torres, A.; Stringer-Reasor, E.; Wallace, A. M.; Pusztai, L.; Boughey, J. C.; Ellis, E. D.; Elias, A. D.; Lu, J.; Lang, J. E.; Han, H. S.; Clark, A. S.; Nanda, R.; Northfelt, D. W.; Khan, Q. J.; Viscusi, R. K.; Euhus, D. M.; Edmiston, K. K.; Chui, S. Y.; Kemmer, K.; Park, J. W.; Liu, M. C.; Olopade, O.; Leyland-Jones, B.; Tripathy, D.; Moulder, S. L.; Rugo, H. S.; Schwab, R.; Lo, S.; Helsten, T.; Beckwith, H.; Haugen, P.; Hylton, N. M.; Van't Veer, L. J.; Perlmutter, J.; Melisko, M. E.; Wilson, A.; Peterson, G.; Asare, A. L.; Buxton, M. B.; Paoloni, M.; Clennell, J. L.; Hirst, G. L.; Singhrao, R.; Steeg, K.; Matthews, J. B.; Asare, S. M.; Sanil, A.; Berry, S. M.; Esserman, L. J.; Berry, D. A.; JAMA oncology
  • Body Composition, Serum Biomarkers of Inflammation and Quality of Life in Clinically Stable Women with Estrogen Receptor Positive Metastatic Breast Cancer. Sheean, P.; Gomez-Perez, S.; Joyce, C.; Vasilopoulos, V.; Bartolotta, M. B.; Robinson, P.; Lo, S.; Lomasney, L.; Nutrition and cancer
  • Phase II Feasibility Study of a Weight Loss Intervention in Female Breast and Colorectal Cancer Survivors (SWOG S1008). Greenlee, H.; Lew, D. L.; Hershman, D. L.; Newman, V. A.; Hansen, L.; Hartman, S. J.; Korner, J.; Shi, Z.; Sardo Molmenti, C. L.; Sayegh, A.; Fehrenbacher, L.; Lo, S.; Klemp, J.; Rinn, K.; Robertson, J. M.; Unger, J.; Gralow, J.; Albain, K.; Krouse, R.; Fabian, C.; Obesity (Silver Spring, Md.)
  • Brief spiritual well-being screening is nonlinearly related to psychological distress in ambulatory cancer patients. Gerhart, J.; Fitchett, G.; Lillis, T. A.; Kuzel, T. M.; Lo, S. S.; Penedo, F.; Weldon, C. B.; Diaz, A.; Psycho-oncology
  • Association of 70-Gene Signature Assay Findings With Physicians' Treatment Guidance for Patients With Early Breast Cancer Classified as Intermediate Risk by the 21-Gene Assay. Tsai, M.; Lo, S.; Audeh, W.; Qamar, R.; Budway, R.; Levine, E.; Whitworth, P.; Mavromatis, B.; Zon, R.; Oldham, D.; Untch, S.; Treece, T.; Blumencranz, L.; Soliman, H.; JAMA oncology
  • How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention? Crew, K. D.; Albain, K. S.; Hershman, D. L.; Unger, J. M.; Lo, S. S.; NPJ breast cancer
  • The tolerance of gastrointestinal organs to stereotactic body radiation therapy: what do we know so far? Thomas, T. O.; Hasan, S.; Small, W.; Herman, J. M.; Lock, M.; Kim, E. Y.; Mayr, N. A.; Teh, B. S.; Lo, S. S.; Journal of gastrointestinal oncology
  • Extrapulmonary small cell carcinoma of the anal canal: a case report and review of the literature. Eberhardt, J. M.; Brown, K.; Lo, S.; Nagda, S.; Yong, S.; Case reports in medicine
  • Impact of multigene assays in early stage breast cancer. Lo, S. S.; Albain, K. S.; The oncologist
  • Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation. Grudzien, P.; Lo, S.; Albain, K. S.; Robinson, P.; Rajan, P.; Strack, P. R.; Golde, T. E.; Miele, L.; Foreman, K. E.; Anticancer research
  • A phase II study of weekly docetaxel in combination with capecitabine in advanced gastric and gastroesophageal adenocarcinomas. Lo, S. S.; Khorana, A. A.; Javle, M.; Simon, S.; Kiefer, G.; Rajasenan, K.; Wang, H.; Hantel, A.; Shayne, M.; Hwang, J.; Schmotzer, A.; Ramanathan, R. K.; Oncology
  • Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection. Lo, S. S.; Mumby, P. B.; Norton, J.; Rychlik, K.; Smerage, J.; Kash, J.; Chew, H. K.; Gaynor, E. R.; Hayes, D. F.; Epstein, A.; Albain, K. S.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Endocrine Therapy with Selective Estrogen Receptor Modulators (SERMs) and Aromatase Inhibitors in the Prevention and Adjuvant Therapy Settings. Lo, S. S.; Pritchard, K. I.; Robinson, P.; Albain, K. S.; Cancer treatment and research
  • Long-term follow-up of 111In-capromab pendetide (ProstaScint) scan as pretreatment assessment in patients who undergo salvage radiotherapy for rising prostate-specific antigen after radical prostatectomy for prostate cancer. Nagda, S. N.; Mohideen, N.; Lo, S. S.; Khan, U.; Dillehay, G.; Wagner, R.; Campbell, S.; Flanigan, R.; International journal of radiation oncology, biology, physics
  • Unusual thoracic problems in patients with malignancies: case 1. Neuroblastoma presenting with intracardiac tumor thrombus. Nagda, S. N.; Lo, S. S.; Melian, E.; Manera, R.; Emami, B.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Neoadjuvant therapy: an emerging concept in oncology. Tanvetyanon, T.; Clark, J. I.; Campbell, S. C.; Lo, S. S.; Southern medical journal